182 related articles for article (PubMed ID: 10720545)
1. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
4. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
5. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
6. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
Storlie J; Maresova L; Jackson W; Grose C
J Infect Dis; 2008 Mar; 197 Suppl 2():S49-53. PubMed ID: 18419408
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS
J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
Toi CS; Dwyer DE
J Clin Virol; 2008 Sep; 43(1):18-24. PubMed ID: 18479962
[TBL] [Abstract][Full Text] [Related]
10. Genotyping of different varicella vaccine strains.
Sauerbrei A; Zell R; Harder M; Wutzler P
J Clin Virol; 2006 Oct; 37(2):109-17. PubMed ID: 16905356
[TBL] [Abstract][Full Text] [Related]
11. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
13. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
Chow VT; Lim KP
Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
[TBL] [Abstract][Full Text] [Related]
14. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.
Gomi Y; Imagawa T; Takahashi M; Yamanishi K
J Med Virol; 2000 Aug; 61(4):497-503. PubMed ID: 10897069
[TBL] [Abstract][Full Text] [Related]
15. Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Sauerbrei A; Zell R; Wutzler P
Intervirology; 2007; 50(1):40-4. PubMed ID: 17164556
[TBL] [Abstract][Full Text] [Related]
16. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus isolates, but not the vaccine strain OKA, induce sensitivity to alpha-1 and beta-1 adrenergic stimulation of sensory neurones in culture.
Schmidt M; Kress M; Heinemann S; Fickenscher H
J Med Virol; 2003; 70 Suppl 1():S82-9. PubMed ID: 12627494
[TBL] [Abstract][Full Text] [Related]
19. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
Cohrs RJ; Gilden DH; Gomi Y; Yamanishi K; Cohen JI
J Virol; 2006 Mar; 80(5):2076-82. PubMed ID: 16474115
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
